Study of effect of Ayurvedic drug, Kantakari Avaleha in Cough of children.

Clinical evaluation of Kantakari Avlehha in Kaphaja Kasa in children

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/12/047978

Enrollment

Registered

2022-12-08

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R05- Cough

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients between the age group of 5-16 years irrespective of gender 2 Primarily the patients will be selected on the basis of the presence of classical symptomatology of Kaphaja Kasa.

Exclusion criteria

Exclusion criteria: 1 Children below 5 years or above 16 years will be excluded 2 Patient presenting with symptoms other than Kaphaja Kasa 3 Patient present with pneumonia chronic obstructive pulmonary disease (COPD) Emphysema Diphtheria Asthma pertussis or congenital anomalies 4 Patient associated with systemic illness such as Tuberculosis HIV and other chronic debilitating disease

Design outcomes

Primary

Measure	Time frame
Relife in Subjective parameters like 1 Kasa (cough) 2 Kaphanishthivana (expectoration) 3 Aruchi (anorexia) 4 Peenus (rhinorrhea) 5 Mandagni (loss of appetite) 6 Shirashoola (Headache) 7 Chardi (vomiting)Timepoint: 1st 7th 14th days	—

Secondary

Measure	Time frame
Relife in Objective parameters like Routine Blood Examinations ( HB TLC DLC ESR) AEC (Absolute Eosinophil Count) Montoux teat for exclusion if necessary X- ray of chest if necessaryTimepoint: 14th days	—

Countries

India

Contacts

Public ContactDr GP Garg

UAU Gurukul Campus Haridwa

drgarggp@gmail.com6395611281

Outcome results